Comprehensive analysis of the BID gene to uncover the role of novel alternative splicing isoforms in colon adenocarcinoma: a systematic review of literature and bioinformatics analysis
BID, specifically the BID-EL isoform, serves as a prognostic and diagnostic biomarker in COAD, highlighting the need for further research on its potential as a therapeutic target in this disease.
Authors
- Leyla Sharifi Aliabadi (ORCID: https://orcid.org/0000-0002-7111-1483)
- Radman Mazloomnejad (ORCID: https://orcid.org/0000-0001-8888-299X)
- Ehsan Nazemalhosseini Mojarad (ORCID: https://orcid.org/0000-0001-8914-004X)
- Alireza Zangooie
- Armin Ahmadi (ORCID: https://orcid.org/0000-0003-0562-9708)
- Arvin Shahmoradi
- Aram Halimi (ORCID: https://orcid.org/0000-0002-7339-4747)
- Moein Piroozkhah (ORCID: https://orcid.org/0000-0003-3061-388X)
- Flora Forouzesh (ORCID: https://orcid.org/0000-0002-2747-3479)
- Zahra Eghbali
- Zahra Salehi (ORCID: https://orcid.org/0000-0002-0839-2729)
- Zahra Alitotonchi
- Kimya Qaderi
- Hooman Ghazizadeh Ahsaei
Institutions
- Islamic Azad University South Tehran Branch (IR)
- University of Leicester (GB)
- Islamic Azad University Medical Branch of Tehran (IR)
- Kurdistan University of Medical Sciences (IR)
- Research Institute for Endocrine Sciences (IR)
- Stem Cell Technology Research Center (IR)
- Shahid Beheshti University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
- Birjand University of Medical Sciences (IR)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2025-11-19
- DOI
- https://doi.org/10.1186/s12935-025-04031-2
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00